SCHEMBL7864758

SCHEMBL7864758

NC(=O)Nc1cccc(C(=O)Nc2cccc(CC(C(=O)O)c3ccccc3)c2)c1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 3/20 0.47
KCNK3 O14649 2/20 0.47
KCNK9 Q9NPC2 2/20 0.47
NR1H4 Q96RI1 2/20 0.46
ALDH1A1 P00352 1/20 0.46
SIRT1 Q96EB6 2/20 0.46
EPHX1 P07099 1/20 0.45
LMNA P02545 2/20 0.45
MAPT P10636 1/20 0.45
SMN1; SMN2 Q16637 1/20 0.45
NOS3 P29474 1/20 0.45
NOS1 P29475 1/20 0.45
NOS2 P35228 1/20 0.45
HPSE Q9Y251 1/20 0.44
POLB P06746 1/20 0.44
PTGES O14684 1/20 0.44
PKM P14618 1/20 0.44
MEN1 O00255 1/20 0.44
ITGB3 P05106 1/20 0.44
ITGA2B P08514 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7866954 0.93 KMT2A (0.47) KMT2AKCNK3KCNK9NR1H4ALDH1A1
SCHEMBL7856443 0.85 LMNA (0.45) KMT2AKCNK9NR1H4ALDH1A1LMNA
SCHEMBL7856532 0.80 CA1 (0.51) KMT2AALDH1A1LMNAMAPTNOS3
SCHEMBL7862052 0.79 MAPK1 (0.52) KMT2AALDH1A1LMNAMAPTSMN1; SMN2
SCHEMBL7856232 0.77 KCNK3 (0.50) KMT2AKCNK3KCNK9SIRT1MAPT
SCHEMBL7378809 0.76 NR1H4 (0.50) KMT2ANR1H4ALDH1A1MEN1ITGB3
SCHEMBL10869967 0.76 ALDH1A1 (0.60) KMT2AALDH1A1EPHX1SMN1; SMN2POLB
SCHEMBL8500048 0.75 LMNA (0.50) KMT2AALDH1A1LMNAMAPTSMN1; SMN2
SCHEMBL7739117 0.75 KCNK3 (0.82) KMT2AKCNK3KCNK9ALDH1A1SIRT1
SCHEMBL2839379 0.73 MAPK1 (0.55) KMT2AKCNK3KCNK9NR1H4ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0889877-B1 META-SUBSTITUTED PHENYLENE DERIVATIVES AND THEIR USE AS ALPHAvBETA3 INTEGRIN ANTAGONISTS OR INHIBITORS SEARLE & CO (US) 2001-08-29 EP claimed